Prenatal 19 By Cypress Pharmaceutical Overview & Drug Interactions

Check For Interactions With Prenatal 19

Supplement: Prenatal 19 by Cypress Pharmaceutical

Prenatal 19 Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Prenatal 19 by Cypress Pharmaceutical

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
UPC/BARCODE 360258196017

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin A
1000 IU
Vitamin A 13%
Vitamin C
100 mg
Vitamin C 167%
Vitamin D3
400 IU
Vitamin D 100%
Vitamin E
30 IU
Vitamin E 100%
Vitamin B1
3 mg
Thiamin 176%
Vitamin B2
3 mg
Riboflavin 150%
Niacinamide
15 mg
Niacin 75%
Vitamin B6
20 mg
Vitamin B6 800%
Folic Acid
1 mg
Folate 125%
Vitamin B12
12 mcg
Vitamin B12 150%
Pantothenic Acid
7 mg
Pantothenic Acid 70%
Calcium
200 mg
Calcium 15%
Iron
29 mg
Iron 161%
Zinc
20 mg
Zinc 133%
Docusate Sodium
25 mg
Docusate Sodium --

Other Ingredients:
Microcrystalline Cellulose
Croscarmellose Sodium
Maltodextrin
Hypromellose
Starch
Stearic Acid
Titanium Dioxide
Pharmaceutical Glaze
Dicalcium Phosphate
Acacia
Crospovidone
Sodium Lauryl Sulfate
Citric Acid
Magnesium Silicate
Magnesium Stearate
Triacetin
Sucrose
Soy Polysaccharides
Sodium Benzoate
Mineral Oil
Polyvinylpyrrolidone
Silica
Sodium Ascorbate
Mixed Tocopherols
Triglycerides
Tricalcium Phosphate


Label Statments:


General Statements
- 60258-196-01
- For Professional Use Only
- N
Precautions
- WARNINGS: WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.
- Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B-12 is deficient. PRECAUTIONS: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.
- ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and paranteral administration of folic acid.
- Keep out of the reach of children.
- CONTRAINDICATIONS: Prenatal 19 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
- DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.
- This product contains soy.
Storage
- STORAGE: Store at room temperature, USP.
FDA Statement of Identity
- Dietary Supplement
Formula
- This product contains soy.
Suggested/Recommended/Usage/Directions
- DIRECTIONS: One tablet daily or as directed by a physician.
General
- L480 Rev. 01/11

Brand Information

See all products by this brand

Distributed By
Name Cypress Pharmaceutical, Inc.
Street Address 135 Industrial Blvd.
City Madison
State MS
ZipCode 39110
To report a serious adverse event or to obtain product information, contact
Phone Number (800) 856-4393

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.